BioNTech SE Contingent Consideration Recognised As Of Acquisition Date
BioNTech SE (BNTX) had Contingent Consideration Recognised As Of Acquisition Date of EUR 2.20 million as of 2023-07-31, per its 20-F filed 2024-03-20.
Discontinued › Notes
ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate · last filed 2024-03-20
- 2023-07-31: Contingent Consideration Recognised As Of Acquisition Date 2.20M EUR.
| Period end | Contingent Consideration Recognised As Of Acquisition Date |
|---|---|
| 2023-07-31 | 2.20M EUR 20-F · filed 2024-03-20 |